Compare Ascendis Pharma A/S (ASND) vs Vistra Corp (VST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Vistra Corp — how do they compare? Ascendis Pharma A/S trades at $255.5 (market cap $16.67B), while Vistra Corp trades at $148.69 (market cap $48.64B). The key difference: Vistra Corp is far larger — about 2.9× Ascendis Pharma A/S's market cap, and Vistra Corp pays a 0.63% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | VST | |
|---|---|---|
Market Cap | $16.67B | $48.64B |
Sector | Health | Technology |
52-Week High | $277.18 | $217.92 |
52-Week Low | $189.74 | $134.71 |
Enterprise Value | $17.04B | $70.58B |
Dividend Yield | — | 0.63% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Vistra Corp
Vistra is a leading integrated retail electricity and power generation company that serves as a critical infrastructure provider for the digital economy. It operates a diversified portfolio of zero-carbon nuclear and renewable assets alongside a massive, flexible natural gas fleet, positioning it as an indispensable partner for energy-intensive AI data centers and industrial electrification.
Read more on VST →
